Introduction
Epidural analgesia is the most popular and effective method of labour pain relief available in clinical practice today, but spinal analgesia and combined spinal epidurals are also increasingly used to guarantee more rapid and reliable obstetric analgesia.
Despite the abundant knowledge on these effective methods, there is still wide variation in the availability and usage of obstetric analgesic services, both regionally and internationally. Political, economical, cultural and psychosocial forces in¯uence this complex matter, and we should also consider the attitudes and needs of the parturient herself, arising from her personal background and childbirth education.
In modern delivery units with good anaesthetic facilities available on a 24 h basis and a willingness to appropriate labour pain control, the epidural rate may reach 60±80% [1 . ,2 . . ,3 . ,4 . ].
The purpose of this article is to review the techniques and medication currently used in obstetric regional analgesia to provide safe and effective pain relief in labour and delivery and to point out some optional modes of labour pain control.
Choice of technique for neuraxial analgesia: labour epidural analgesia, combined spinal±epidural analgesia or intrathecal analgesia?
Labour pain is a complex, subjective and multidimensional experience with marked individual variation, and clinicians should therefore tailor the analgesic regimen to meet individual analgesic requirements during the progress of labour and delivery. The epidural infusions used most frequently today contain 0.1% or less bupivacaine or a stereoisomeric local anaesthetic with an opioid to sustain mobility and minimize the effect of analgesia on the mode of delivery [5 . ,6 . ,7,8 . ]. It has been shown that 12±35% of parturients request supplemental medication because of breakthrough pain in labour under continuous infusion of labour epidural analgesia (LEA) [9, 10] . In other words, the need for medication required for the initiation of epidural analgesia may increase two-to threefold from early to late labour along with the increasing pain intensity.
It is up to local preference if LEA is administered as continuous infusion, intermittent boluses or patientcontrolled epidural analgesia (PCEA), and all these modes of delivery provide a similar level of satisfactory pain relief [5 . ,7,11,12 . ]. In contrast, PCEA may be a more attractive mode of relieving pain, depending on the patient's psychological characteristics, because it allows the parturient to self-medicate and to control her own analgesia without staff intervention [8 . ,10,12 . ].
Not all parturients, however, are satis®ed with the effect of LEA. The risk factors include, for example, nulliparity, dysfunctional labour, profound fear of childbirth and suspicion of instrumental delivery. In such cases, combined spinal±epidural (CSE) analgesia is suggested as a feasible option. It provides immediate pain relief and results in fewer requests for supplementation of analgesia than LEA [13 . ±15 . ,16 . . ,17 . ,18 . ]. CSE has been used with different drugs and combinations, ranging from opioids alone to multiple combinations of local anaesthetics, and other drugs with analgesic properties. The local anaesthetic in most extensive intrathecal use is bupivacaine. The doses administered range from 1 to 2.5 mg combined with an opioid (mostly sufentanil or fentanyl). The analgesia is usually continued as needed, using the epidural technique [14 . ,16 . . ,17 . ,19] .
In clinical practice, it is not always possible to use the epidural technique, and using a single injection of intrathecal opioid or local anaesthetic combined with an opioid or additives, such as clonidine (intrathecal analgesia, ITA), may provide adequate analgesia in spite of the limited duration of pain relief with ITA. A metaanalysis of single-injection intrathecal opioids versus epidural local anaesthetics in labouring parturients failed to reveal any differences in the outcome/mode of delivery [20 . . ].
Postdural puncture headache
When we began to use spinal analgesia in our practice, one of the main concerns was the potentially increasing incidence of postdural puncture headache (PDPH) and the need for epidural blood patches with the consequent increase in costs. Both clinical practice and literature, however, have shown that no such increase takes place [18 . ]. According to recent studies of Paech et al. [21] and Rutter et al. [22] , the rate of accidental dural punctures in conjunction with LEA is 0.5±0.8%. These instances are associated with a PDPH rate of 71±81%. According to the study of Landau et al.
[23] on complications of combined spinal±epidural labour analgesia, the rate of PDPH was 0.7% and the need for epidural blood patches was 0.36% when a 27-gauge Whitacre needle was used. These ®gures agree with our clinical experience and support the usage of CSE and ITA as options for labour analgesia.
Ambulation
Ambulation is commonly believed to be of value for the progression of active labour.
In our hospital, midwives are most opposed to LEA, their main arguments being that LEA is`unnatural', ties the mother to the bed, causes paralysis of the legs and slows down the progression of labour and delivery. Our experience with mobile LEA, however, is that few mothers (530%) want to ambulate, in accordance with other studies [24 . . ] .
In contrast, a recent prospective, randomized study failed to show any advantage of ambulation during mobile epidurals on the duration of labour, the use of oxytocin, the mode of delivery or the maternal and neonatal outcome [6 . ]. Golara et al. [25 . ], who studied the effects of mobilization on the second stage of labour, found it to shorten the active pushing phase at the second stage, but to have no effect on the mode and outcome of labour and delivery.
Choice of local anaesthetic
Bupivacaine continues to be the most commonly used local anaesthetic in obstetrics, but single-isomer local anaesthetics, such as ropivacaine and levo-bupivacaine, have been developed to improve safety.
Ropivacaine
Ropivacaine has gained popularity as an agent for LEA because of its purportedly lesser toxicity and greater selectivity for block of sensory ®bres compared with bupivacaine [26 . . ,27]. Previous studies, however, have suggested that ropivacaine is 40% less potent than bupivacaine in epidural analgesia, based on the 50% effective dose values used in up-and-down sequential allocation studies [28, 29] . Chua et al. [12 . ] demonstrated that ropivacaine 0.125% and bupivacaine 0.125% were clinically indistinguishable in terms of pain relief in LEA administered via PCEA. Similar results of clinically indistinguishable initiation and maintenance of labour analgesia by 0.075% ropivacaine with fentanyl 2 mg/ml versus 0.075% bupivacaine with fentanyl 2 mg/ml were obtained by Owen et al. A recent intrathecal study comparing ropivacaine and bupivacaine for potency suggested that the anaesthetic ratio between spinal ropivacaine and bupivacaine is 2:3 [33] . Hughes et al. [34 . ], however, compared intrathecally 2.5 mg of ropivacaine with 2.5 mg of bupivacaine, both with fentanyl 25 mg, and demonstrated equal labour analgesia, but less motor block in the case of ropivacaine. Soni et al. [15 . ] also showed that low-dose (3 mg) intrathecal ropivacaine with or without sufentanil (10 mg) provided effective labour analgesia without a loss of lower extremity motor function, which is a bene®cial feature, especially in settings where ambulation should be retained. 
Options of spinal opioids
Intrathecal lipid-soluble opioids provide rapid, effective analgesia with minimal changes in blood pressure and motor function [19,36 . . ,37 . ]. The spinal opioids most frequently used in obstetrics are fentanyl in a single dose of 10±25 mg and sufentanil 2±5 mg, which both provide analgesia of similar duration and quality when added in equal doses to a solution of local anaesthetic, such as bupivacaine. Cheng et al. [14 . ] found the combination of intrathecal sufentanil 5 mg and bupivacaine 1.25 mg to be equally effective as fentanyl 25 mg plus bupivacaine 1.25 mg in early labour, with a mean duration of analgesia of 109± 118 min. The authors suggested that no further dose reduction of either the opioid or bupivacaine should be made, as that would predispose to a higher rate of analgesic failures.
Stock et al. [38] found that the addition of a small 5 mg dose of intrathecal fentanyl to bupivacaine provided a similar dose-sparing effect of bupivacaine as did doses of 15 and 25 mg of fentanyl, while the higher doses resulted in a longer duration of analgesia but an increased incidence of side effects.
Adverse effects of opioids are more common with intrathecal than epidural use [24 . . ]. The most typical mild but annoying side effects, such as pruritus, nausea/ vomiting and sedation, are usually more pronounced in connection with spinal opioids, but the side effects of therapeutic doses are generally mild and easy to treat [15 . ,16 . . ,20 . . ,39].
Potentially more severe adverse effects, such as foetal heart rate abnormalities, low Apgar scores, need for neonatal resuscitation, uterine hypertonus, maternal respiratory depression and hypotension, are related to higher doses of spinal opioids, which should always raise some concern. The usage of higher doses in obstetric practice should be reevaluated [24 . . ,40 . . ]. When spinal opioids are combined with an intrathecal local anaesthetic, proprioceptive de®cit, perineal squeezing impairment and motor block should also be considered [16 . . ] . Published studies, however, indicate that intrathecal opioids provide comparable analgesia of limited duration and an increased rate of adverse effects compared with LEA [20 . . ].
Additives with spinal analgesics
With the aim of prolonging the duration of spinal analgesia without LEA, certain adjuvant drugs (additives) have been combined with spinal opioids/local anaesthetics.
Vercauteren et al. [41 . . ] found that adrenaline added to spinal bupivacaine-sufentanil at a low dose of 2.25 mg signi®cantly prolonged the duration of intrathecal labour analgesia.
Clonidine has been used in combination with subarachnoid bupivacaine and opioid in doses of 50±200 mg to prolong the duration of spinal analgesia. In clinical use, however, clonidine may result in more hypotension and sedation. In a randomized, double-blind study, Paech et al. [42 . ] were unable to show any clinical bene®t of clonidine administered in doses of less than 50 mg in combination with subarachnoid fentanyl and bupivacaine administered for CSE during active labour.
The use of neostigmine in the clinical routine is problematic due to the predictable incidence of untoward effects. D'Angelo et al. [43 . . ] combined spinal bupivacaine, clonidine and sufentanil with and without neostigmine to prolong labour analgesia, but they found that spinal neostigmine produced severe nausea and did not further enhance the duration of spinal labour analgesia.
Some controversies related to labour epidural analgesia
For years, there has been considerable controversy among anaesthesiologists and obstetricians concerning the relationship between LEA and outcome of labour and delivery [2 . . ].
Mode of labour and delivery
The recent study by Sharma and colleagues [44 . . ], which was well controlled and randomized and included 459 healthy nulliparas in spontaneous labour with either epidural analgesia or intravenous pethidine, revealed no statistical differences in the rate of caesarean deliveries, and the rate of spontaneous vaginal delivery was over 80% in both groups. The parturients with LEA, however, had prolonged ®rst and second stages of labour and an elevated rate of instrumental deliveries.
Thus, LEA appears to have some effects on the outcome of labour and delivery, but it is important to notice that the technique of LEA has been under continuous modi®cation. The earlier LEA methods with more concentrated local anaesthetic may have had a more pronounced in¯uence on the progress and outcome of labour and delivery. As shown in the randomized control trial of the Comparative Obstetric Mobile Epidural Trial Study Group [24 . . ], which compared traditional epidural analgesia with low-dose techniques, the new modi®ed technique resulted in fewer instrumental deliveries and a shorter duration of the second stage. There was, however, a signi®cant difference in the neonatal outcome in favour of traditional epidurals. The increased use of fentanyl in the new techniques might explain this disadvantage.
Maternal fever and neonatal sepsis
Recently, there has been a great deal of debate in clinical practice and in the literature about the possible relationship of LEA with maternal fever and neonatal sepsis. Vallejo et al. [4 . ] evaluated (retrospectively) the data of over 14 000 parturients, including (1) parturients with amnionitis and without LEA, (2) parturients with amnionitis and with LEA and (3) parturients without amnionitis and with LEA. They failed to show any association between maternal fever and LEA in the parturients who did not have concomitant amnionitis. Kaul et al. [45 . . ] examined the association of LEA with maternal fever and the neonatal sepsis evaluation rate in a group of 922 nulliparas compared with 255 nulliparas with parenteral analgesics. The authors found an association of LEA with maternal fever but not with the neonatal sepsis evaluation rate. Their study design was retrospective and not randomized, which may have caused some selection bias. It is known that LEA is chosen for analgesia in dif®cult labours, including those that are more painful, induced, dysfunctional or prolonged, require more obstetric interventions etc., and these factors may also predispose the parturients to elevated temperature. Thus, LEA may be associated with a rise in maternal temperature (per se?), but its clinical signi®cance is still uncertain.
If epidural fails, what are the options?
In clinical practice, there may be several things that affect the success of LEA. It is known that obstetric patients may pose an even greater challenge, due to the physiological changes produced by pregnancy, compared with surgical patients [46 . ]. Failure in the induction of epidural analgesia may be due to technical problems or problems relating to the patient's intrinsic features/ preexisting diseases. Alternatively, LEA may cause inadequate analgesia due to the marked individual variation in the subjective sensation of pain, or LEA may be too slow to relieve intense pain in rapidly progressing delivery.
In such cases, ITA may be a good solution and in some special cases with a contraindication to regional analgesia (i.e. coagulopathy, anticoagulation treatment), intravenous remifentanil may be an option.
Intrathecal analgesia
Lim et al. [37 . ] showed that intrathecal fentanyl 25 mg alone provided good analgesia for approximately 2 h in early labour, but it has been shown that the effect is not suf®cient for the whole period of labour and delivery. Yeh et al. [39] demonstrated that an intrathecal combination of 25 mg of fentanyl, 2.5 mg of bupivacaine and 150 mg of morphine produced satisfactory analgesia for more than 4 h with acceptable side effects. Spinal clonidine combined with a local anaesthetic and an opioid prolonged labour analgesia, but a combination with neostigmine produced no further advantage and induced severe nausea [43 . . ].
Remifentanil
Remifentanil, a new ultrashort-acting m-receptor agonist, has rapid onset and offset with a plasma contextsensitive half-life of 3 min. It rapidly crosses the placenta but is quickly metabolized and distributed in the fetus [47 . . ]. These features should make it an ideal drug for obstetric analgesia whenever there are contraindications for regional analgesia. Bolus doses of 0.2±0.5 mg/kg in patient-controlled analgesia and continuous infusion of 0. ], the administration of remifentanil is associated with a high incidence (approximately in 60% of the study parturi-ents) of maternal respiratory depression, as evidenced by peripheral oxygen desaturation.
Thus, the role of remifentanil in obstetric analgesia will be under research until a safety pro®le is established.
Safety aspects of regional analgesia
Neuraxial analgesia is now safer than ever. Modern lowdose spinal±epidural regimens provide ef®cacious analgesia, stable maternal haemodynamics and few, tolerable side effects [6 . ,8 . ,11,19,20 . . ]. As shown by Hawthorne et al. [52 . . ], the modern epidural technique maintains a stable mean arterial pressure and cardiac index regardless of whether or not preloading is used. According to these ®ndings, maternal hypotension appears highly unlikely during regional analgesia in clinical practice, and if some hypotension occurs, it is mild and easily treatable. This is related to the fact that the dose of local anaesthetic administered for analgesia has been reduced ®ve to tenfold from the ®rst attempts to use epidural analgesia for obstetric pain relief. In spite of that, complications are possible due to the invasive nature of neuraxial analgesia, the in¯uence of the drugs used in neuraxial anaesthesia, patient characteristics such as comorbidities, or medical malpractice. Severe complications are extremely rare, published mainly as case reports [8 . ,24 . . ,25 . ,53 . ,54± 56]. High doses of intrathecal opioids, however, involve serious side effects [20 . . ,24 . . ,40 . . ].
Conclusions
Up till now, there has been no single new drug to overcome the superiority of LEA used in obstetric analgesia. Rather, the multiple drug regimens of neuraxial analgesia have turned out to be very safe options. These techniques allow the parturient to participate actively in the course of labour and delivery, preserving motor function and strength for pushing during the second stage. Thus, the outcome of labour and delivery and the welfare of the neonate are minimally affected without compromising the quality of analgesia [20 . . ,24 . . ].
Currently, anaesthesiologists can offer excellent analgesic services, but there are still remarkable disparities in the availability and provision of these methods. Uninformed parturients in pain cannot make a free, sensible choice of the available pain relief methods, but need guidance and assistance from health care professionals.
Thus, in order to improve the quality of obstetric analgesic care, anaesthesiologits, as pain experts, should take more responsibility for obstetric pain problems and provide the antenatal and perinatal health care professionals with information on the recent advances in pain research.
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